ALC: Alcon Inc

ALC新闻

• Seeking Alpha 15:53 Parnassus Mid Cap Growth Fund Q2 2025 Commentary
• Seeking Alpha 15:30 Parnassus Mid Cap Fund Q2 2025 Commentary
• Seeking Alpha 14:00 Harding Loevner Global Equity Q2 2025 Report
• Investing 12:31 Stifel reiterates Buy rating on Alcon stock, maintains $100 price target
• Investing 10:21 RxSight stock rating downgraded to Neutral by BTIG amid sales challenges
• Investing 13:09 Alcon’s vitreoretinal-cataract system receives Health Canada approval
• Investing 12:10 Alcon to acquire LumiThera and its dry AMD light therapy device
• Investing 13:57 DP World subsidiary to acquire 51% stake in NovaAlgoma cement assets
• Investing 12:06 Stifel reiterates Buy rating on Alcon stock amid IOL market dynamics
• Investing 09:56 UBS downgrades Galderma to “neutral” on valuation concerns, softer aesthetics
• Investing 13:20 Alcon Canada Earns Global Recognition as a Top Employer
• Investing 13:10 # Alcon’s new eye lens reduces light scatter for cataract patients
• Seeking Alpha 07:49 Impax Global Social Leaders Fund Q1 2025 Commentary (Mutual Fund:IGSLX)
• Investing 11:50 UBS identifies stock winners amid structural growth tailwinds
• Seeking Alpha 11:30 Alcon’s Tryptyr Adds Growth, But Valuation Keeps Shares On 'Hold' (NYSE:ALC)
• Investing 11:01 Citi more constructive on EU MedTech: Upgrades Demant; Alcon top pick
• Seeking Alpha 15:35 Thornburg Better World International Fund Q1 2025 Commentary
• Investing 07:46 BofA Securities lowers Alcon stock price target after Q1 results
• Investing 07:30 Analysts assess the potential impact of Trump’s surprise 50% steel tariffs
• Investing 06:50 Citi maintains Buy on Alcon, price target CHF99 after FDA nod
• Seeking Alpha 05:54 Madison Large Cap Fund Q1 2025 Investment Strategy Letter
• Benzinga 17:28 Alcon Secures First FDA Approval Since Novartis Spin-Off In 2019 - Alcon (NYSE:ALC)
• Investing 09:39 BTIG maintains Alcon $99 target, upbeat on TRYPTYR launch
• Investing 20:44 FDA approves Alcon’s TRYPTYR for Dry Eye Disease treatment